Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 3c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
• General Mills (GIS) Tops Q1 EPS by 3c